Pharmacology of heart failure: From basic science to novel therapies.

Lother, Achim; Hein, Lutz

Lother, Achim; Hein, Lutz.

Affiliation

Lother A; Institute of Experimental and Clinical Pharmacology and Toxicology, Faculty of Medicine, University of Freiburg, Freiburg, Germany; Heart Center, Department of Cardiology and Angiology I, Faculty of Medicine, University of Freiburg, Freiburg, Germany. Electronic address: achim.lother@universitaets-herzzentrum.de.
Hein L; Institute of Experimental and Clinical Pharmacology and Toxicology, Faculty of Medicine, University of Freiburg, Freiburg, Germany; BIOSS Centre for Biological Signaling Studies, University of Freiburg, Freiburg, Germany. Electronic address: lutz.hein@pharmakol.uni-freiburg.de.

Pharmacol Ther ; 166: 136-49, 2016 10.

Article de En | MEDLINE | ID: mdl-27456554

Sujet(s)
Mots clés

Angiotensin receptor and neprilysin inhibitor; Epigenetics; Heart failure; Ivabradine; Mineralocorticoid receptor; Omecamtiv mecarbil

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Agents cardiovasculaires / Défaillance cardiaque Type d'étude: Guideline / Prognostic_studies Limites: Humans Langue: En Journal: Pharmacol Ther Année: 2016 Type de document: Article Pays de publication: Royaume-Uni

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google